Weivoda MM and Hohl RJ |
Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation. |
2011 |
Endocrinology |
pmid:21586555
|
Vlahcevic ZR et al. |
Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. |
1997 |
Gastroenterology |
pmid:9394735
|
Paintlia AS et al. |
Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells. |
2010 |
Glia |
pmid:20578043
|
Pandak WM et al. |
Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in primary cultures of rat hepatocytes. |
2002 |
Hepatology |
pmid:12029625
|
Kojro E et al. |
Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis. |
2010 |
J. Alzheimers Dis. |
pmid:20413873
|
Dawson MJ et al. |
The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. |
1992 |
J. Antibiot. |
pmid:1624366
|
Sidebottom PJ et al. |
The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. II. Structure elucidation. |
1992 |
J. Antibiot. |
pmid:1624367
|
Jones CA et al. |
The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. III. Biosynthesis. |
1992 |
J. Antibiot. |
pmid:1429235
|
Middleton RF et al. |
Novel squalestatins produced by biotransformation. |
1995 |
J. Antibiot. |
pmid:7775268
|
Chen TS et al. |
The preparation of zaragozic acid A analogues by directed biosynthesis. |
1994 |
J. Antibiot. |
pmid:8002393
|
Hasumi K et al. |
Competitive inhibition of squalene synthetase by squalestatin 1. |
1993 |
J. Antibiot. |
pmid:8501015
|
Onishi JC et al. |
Antimicrobial activity of viridiofungins. |
1997 |
J. Antibiot. |
pmid:9186560
|
Cannell RJ et al. |
Production of additional squalestatin analogues by directed biosynthesis. |
1994 |
J. Antibiot. |
pmid:8150722
|
Baxter A et al. |
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo. |
1992 |
J. Biol. Chem. |
pmid:1601846
|
Correll CC and Edwards PA |
Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro. |
1994 |
J. Biol. Chem. |
pmid:8276863
|
Gibbs JB et al. |
Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. |
1993 |
J. Biol. Chem. |
pmid:8463291
|
Lindsey S and Harwood HJ |
Inhibition of mammalian squalene synthetase activity by zaragozic acid A is a result of competitive inhibition followed by mechanism-based irreversible inactivation. |
1995 |
J. Biol. Chem. |
pmid:7721822
|
Ravid T et al. |
The ubiquitin-proteasome pathway mediates the regulated degradation of mammalian 3-hydroxy-3-methylglutaryl-coenzyme A reductase. |
2000 |
J. Biol. Chem. |
pmid:10964918
|
Brusselmans K et al. |
Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. |
2007 |
J. Biol. Chem. |
pmid:17483544
|
Liu CI et al. |
Binding modes of zaragozic acid A to human squalene synthase and staphylococcal dehydrosqualene synthase. |
2012 |
J. Biol. Chem. |
pmid:22474324
|